 SALT LAKE CITY--BUSINESS WIRE--PolarityTE, Inc. Nasdaq: PTE, a company focused on transforming the lives of patients by discovering, designing, and developing a range of regenerative tissue products and biomaterials, announced today the closing of its previously announced registered direct offering. In the offering the company sold 6,670,000 shares the Shares of its common stock, par value 0.001 per share the Common Stock, pre-funded warrants to purchase up to 2,420,910 shares of C 